期刊文献+

MMP-2及TIMP-2在宫颈癌组织中的表达及其对侵袭和转移的影响 被引量:2

Relationships among MMP-2 and TIMP-2 expression,invasiveness and metastasis in cervical carcinoma
下载PDF
导出
摘要 目的通过检测基质金属蛋白酶-2(MMP-2)及基质金属蛋白酶组织抑制物-2(TIMP-2)在宫颈癌中的表达,探讨其对宫颈癌侵袭转移的影响。方法应用免疫组化SP法检测53例宫颈癌和14例正常宫颈组织中MMP-2和TIMP-2的表达情况,并进行χ2检验。结果免疫组化结果显示MMP-2和TIMP-2在宫颈癌组织中表达显著高于正常宫颈组织(P<0.01)。宫颈癌组织中MMP-2和TIMP-2的阳性表达率分别为71.70%和47.17%,MMP-2表达随淋巴结转移的发生而上调,但差异无统计学意义(P>0.05);TIMP-2在有淋巴结转移者显著低于无淋巴结转移者(P<0.01)。MMP-2与TIMP-2的表达有相关性(P<0.05)。结论 MMP-2和TIMP-2的表达与宫颈癌的侵袭转移有关,MMP-2和TIMP-2可作为预测宫颈癌侵袭转移潜能和临床预后的指标。 Objective To study the expression of MMP-2 and TIMP-2 in cervical carcinoma and their effects on the tumor invasiveness and metastasis. Methods The expression of MMP-2 and TIMP-2 in 53eases of cervical carcinomas and 14 cases of normal cervical tissues were detected by immunohistochemistry SP method. Significant differences were analyzed by X2 test. Results The positive rates of both MMP-2 and T1MP-2 were significantly higher in cervical carcinoma than in normal cervices (P〈 0.01). The positive rates of MMP-2 and TIMP-2 were 71.70%and 47.17% respectively . The expression of MMP-2 was no relevant to lymph node metastasis (P〉 0.05). The expression of TIMP-2 decreased significantly with node metastasis (P〈 0.01), There was a correlation between the expression of MMP-2 and TIMP-2(P〈0.05). Conclusion The expression of MMP- 2 and TIMP-2 in cervical carcinoma was significantly associated with the invasion and metastasis of cervical carcinoma. The MMP-2 and TIMP-2 may act as an index to indicate the potential of the invasion and metastasis and the prognosis of cervical carcinoma.
出处 《解剖学研究》 CAS 2011年第3期186-189,共4页 Anatomy Research
基金 黑龙江省教育厅科技研究项目(11541358)
关键词 宫颈癌 基质金属蛋白酶 基质金属蛋白酶组织抑制物 侵袭 转移 Cervical carcinoma Matrix metalloproteinase Tissue inhibitor of matrix metalloproteinase Invasiveness Metastasis
  • 相关文献

参考文献12

  • 1Yong Wook Jung, Sang Wun Kim, Sunghoon Kim, et al. Prevalence and clinical relevance of cyclooxygenase-1 and - 2 expression in stage IIB cervical adenocarcinoma Original Research Article. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2010, 148( 1 ) : 62- 66.
  • 2陈廷玉,卢春凤,张晓波,王景涛,李玉兰.血管内皮生长因子C和nm23表达与微血管密度及宫颈癌转移的关系[J].解剖学研究,2007,29(5):336-339. 被引量:2
  • 3陈廷玉,卢春凤,张东东,王景涛,李玉兰.宫颈癌COX-2、MMP-9和CD105表达与肿瘤血管生成及侵袭转移的关系[J].解剖学研究,2008,30(1):24-27. 被引量:11
  • 4陈廷玉,卢春凤,苗智,邵文武,张晓波.宫颈癌PCNA和PTEN的表达与癌细胞增殖及淋巴结转移的关系[J].解剖学研究,2010,32(1):17-20. 被引量:7
  • 5Kai Kessenbrock, Vicki Plaks, Zena Werb. Matrix Metallo-proteinases: Regulators of the Tumor Microenvironment. Cell, 2010, 141(1,2) : 52-67.
  • 6Agnbs No 1, Maud Jost, Erik Maquoi. Matrix metalloproteinases at cancer tumor-host interface. Seminars in Cell & Developmental Biology, 2008,9( 1 ) : 52-60.
  • 7Dimitra Bourboulia, William G. Stetler-Stevenson. Matrix metalloproteinases (MMPs) and tissue inhibitors of metallo- proteinases (TIMPs) : Positive and negative regulators in tumor cell adhesion. Seminars in Cancer Biology, 2010, 20 (3):161-168.
  • 8Svetlana Kondratiev, Douglas R. Gnepp, Evgeny Yakirevich, et al. Expression and prognostic role of MMP2, MMP9, MMP13, and MMP14 matrix metalloproteinases in sinonasal and oral malignant melanomas. Human Pathology, 2008,39 (3) : 337-343.
  • 9Ruthy Shaco-Levy, Shalom Sharabi, Daniel Benharroch, et al. Matrix metalloproteinases 2 and 9, E-cadherin, and β- catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2008,139(2) : 226-232.
  • 10Sanaa Eissa, Randa Ali-Labib, Menha Swellam, et al. Noninvasive Diagnosis of Bladder Cancer by Detection of Matrix Metalloproteinases (MMP-2 and MMP-9) and Their Inhibitor (TIMP-2) in Urine Original Research Article. European Urology, 2007,52(5) : 1388-1397.

二级参考文献48

  • 1赵建农,王翦,刘运生,王宇田,聂新民.PTTG、bFGF和MMP-9的表达与垂体腺瘤侵袭性的关系[J].中华神经医学杂志,2007,6(3):282-285. 被引量:4
  • 2Aziz SA, Pervez S, Khan SM, et al. Prognostic value of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinoma breast. J Coil Physicians Surg Pak, 2005,15 (4) : 225-229.
  • 3Tsutsui S, Inoue H, Yasuda K, et al. Reduced expression of PTEN protein and its prognostic implications in invasive ductal carcinoma of the breast. Oncology, 2005, 68 (4-6) : 398-404.
  • 4Takei Y, Saga Y, Mizukami H, et al. Overexpression of PTEN in ovarian cancer cells suppresses i.p. dissemination and extends survival in mice. Mol Cancer Ther, 2008,7(3) :704 -711.
  • 5Tomioka A, Tanaka M, De Velasco MA, et al. Delivery of PTEN via a novel gene microcapsule sensitizes prostate cancer cells to irradiation. Mol Cancer Ther, 2008,7(7) : 1864-1870.
  • 6Dellas A, Jundt G, Sartorius G, et al. Combined PTEN and p27kip1 Protein Expression Patterns Are Associated with Obesity and Prognosis in Endometrial Carcinomas. Clin Cancer Res, 2009, 15(7) :2456-2462.
  • 7Yaginuma Y, Yamashita T, Ishiya T, et al. Abnormal structure and expression of PTEN/MMAC1 gene in human uterine cancers. Mol Carcinog, 2000,27 (2) : 110- 116.
  • 8Harima Y, Sawada S, Nagata K, et al. Mutation of the PTEN gene in advanced cervical cancer correlated with tumor progression and poor outcome after radiotherapy. Int J Oncol, 2001,18(3) :493-498.
  • 9Cheung TH, Lo KW, Yim SF, et al. Epigenetic and genetic ahemation of PTEN in cervical neoplasm. Gynecol Oncol, 2004,93 (3) : 621-627.
  • 10Lee JS, Choi YD, Lee JH, et al. Expression of PTEN in the progression of cervical neoplasia and its relation to tumor behavior and angiogenesis in invasive squamous cell carcinoma. J Surg Oncol, 2006,93 (3) : 233-240.

共引文献16

同被引文献38

  • 1李敏,王文福,汪青.宫颈癌中MMP-2及TIMP-2的表达及其临床意义[J].解剖与临床,2004,9(4):241-243. 被引量:7
  • 2赵昀,崔淑慧,任丽华,赵超,魏丽惠.细胞学、HPV高危型检测在宫颈病变筛查中的应用[J].中国妇产科临床杂志,2006,7(2):89-93. 被引量:58
  • 3Parkin DM, Bray F, Ferlay J, et al. Global cancer statis- tics, 2002. CA Cancer J Clin, 2005,55 (2) : 74-108.
  • 4Gustafsson L, Pont6n J, Zack M, et al. International inci- dence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control, 1997,8 ( 5 ) : 755-763.
  • 5Oikonomou P, Mademtzis I, Messinis I, et al. Quantita- tive determination of human telomerase reverse transcrip- tase messenger RNA expression in premalignant cervical lesions and correlation with human papilloma virus load. Hum Pathol, 2006,37 (2) 135-142.
  • 6Heselmeyer-Haddad K, Janz V, Philip E, et al. Detec- tion of genomic amplification of the human telomerase gene(TERC) in cytologic specimens as a genetic test for the diagnosis of Cervical dysplasia. Am J Pathol, 2003, 163 : 1406-1416.
  • 7Hopman AH, Theelen W, Hommelberg PP, et al. Ge- nomic integration of oncogenic HPV and gain of the hu- man telomerase gene TERC at 3@6 are strongly associat- ed events in the progression of uterine cervical dysplasia to invasive cancer. J Pathol, 2006,210(4):412-419.
  • 8Mongel6s P, P6ez M, Rodriguez-Riveros I, et al. Detec- tion of high risk human papillomavirus by hybrid capture II (r) according cytological findings in women treated for squamous intraepithelial lesions of the cervix, period 2006/ 2010. Rev Bras Epidemiol, 2013,16( 1 ) :d0-dS.
  • 9McMurray HR, Mccance DJ. Human papilloma virus typel6 E6 activates TERT gene transcription through in- duction of cMyc and release of USF-mediated repression. J Virol, 2003,77 ( 18 ) : 9852-9861.
  • 10Seo JE, Kim JH, Lee JC, et al. The role of HPV onco- proteins and cellular factors in maintenance of hTERT ex- pression nince rvical carcinoma cells. Gynecol Oncol, 2004,94( 1 ) : 40-47.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部